Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine symbols : NIPNF save search
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Published: 2024-03-05 (Crawled : 07:00) - globenewswire.com
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer collaboration trial
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Published: 2024-01-08 (Crawled : 17:00) - globenewswire.com
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer collaboration
NEC laboratories advances therapeutic cancer vaccine research with new AI model Attentive Variational Information Bottleneck
Published: 2023-07-27 (Crawled : 06:00) - prnewswire.com
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
vaccine cancer research
New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023
Published: 2023-04-18 (Crawled : 09:00) - biospace.com/
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine tumors cancer
Transgene to Host KOL Webinar on TG4050: an Individualized Cancer Vaccine for the Treatment of HPV-Negative Head & Neck Cancers
Published: 2023-04-04 (Crawled : 17:00) - biospace.com/
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer treatment
NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
Published: 2022-03-08 (Crawled : 10:00) - biospace.com/
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
vaccine axim set
Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine
Published: 2021-11-22 (Crawled : 19:00) - biospace.com/
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg405 positive cancer vaccine
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.